Table 1.
31P nuclear magnetic resonance spectroscopy data in patients suffering from preeclampsia (Group 1) and healthy, pregnant women (Group 2). Comparisons between Groups 1 and 2 by means of Students t-test to determine significance (p<0.05)
| Substance | Chemical Shift | Mean Concentration in μmol/L ± SD |
P | |
|---|---|---|---|---|
| Gestosis | Controls | |||
| PI | 0.09 | 55.9 ± 21.2* | 157.6 ± 104.0* | 0.022 |
| LPC 2 | 0.19 | 21.4 ± 12.0* | 47.1 ± 20.2* | 0.007 |
| mmol/l ± sd | ||||
|
| ||||
| PE + SM | 0.52 | 0.71 ± 0.21 | 0.67 ± 0.15 | 0.638 |
| LPC 1 | 0.35 | 0.31 ± 0.03* | 0.17 ± 0.07* | <0.001 |
| PC | -0.09 | 2.41 ± 0.62 | 2.22 ± 0.44 | 0.473 |
| Total PL | 3.51 ± 0.82 | 3.26 ± 0.65 | 0.506 | |
PE + SM, phosphatidylethanolamine and sphingomyelin; LPC, lysophosphatidylcholine; PI, phosphatidylinositol; PC, phosphatidylcholine.